跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 明薇
教授
公共衛生研究所
電話
02-2826-7379
電子郵件
mingweilin
nycu.edu
tw
h-index
h10-index
h5-index
5723
引文
40
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1190
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
396
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1995 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(164)
類似的個人檔案
(6)
指紋
查看啟用 Ming-Wei Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Taiwan
100%
Taiwanese
61%
Polymorphism
53%
Insulin Resistance
48%
National Cohort Study
45%
Single nucleotide Polymorphism
43%
Schizophrenia
42%
Genotype
40%
Chinese Population
39%
Psoriasis
37%
LOD Score
33%
Confidence Interval
31%
Odds Ratio
30%
Primary Dysmenorrhea
29%
Hypertension
29%
Gene Polymorphism
28%
Pedigree
27%
Genetic Polymorphism
27%
Obesity
23%
Chinese Patients
22%
Receptor Gene
20%
Menstrual Pain
20%
Genetic Variants
20%
Type 2 Diabetes Mellitus (T2DM)
19%
Fasting Plasma Glucose
18%
Atopic Dermatitis
18%
Schizophrenic Patients
17%
Gastric Cancer
17%
Susceptibility Loci
16%
Cirrhotic Patients
16%
Psoriasis Vulgaris
16%
Taiwanese Families
16%
Asthma
16%
Cirrhosis
16%
Quantitative Trait Loci
15%
Linkage Analysis
15%
Age of Onset
15%
Coronary Artery Disease
14%
Cytokine Gene Polymorphism
14%
Kawasaki Disease
14%
Tardive Dyskinesia
14%
Postmenopausal Women
14%
Metabolic Syndrome
14%
Comorbidity Profile
14%
Primary Cutaneous Amyloidosis
14%
Genome Scan
14%
Val66Met Polymorphism
14%
Polycystic Ovary Syndrome
14%
Pregnant Women
13%
Family Study
13%
Biochemistry, Genetics and Molecular Biology
Gene Linkage
68%
Insulin Resistance
63%
Allele
57%
Single-Nucleotide Polymorphism
52%
Haplotype
46%
Genotyping
44%
Gene Polymorphism
42%
Promoter Region
32%
Genetic Polymorphism
30%
Cohort Study
27%
Linkage Analysis
26%
Genetic Divergence
25%
Pedigree
23%
Lod Score
22%
Cytokine
22%
Blood Pressure
21%
Glucose Blood Level
21%
Blood Plasma
20%
Receptor Gene
20%
Genetics
20%
Prevalence
17%
Quantitative Trait Locus
15%
Hepatitis B Virus
15%
Amyloidosis
14%
Heme Oxygenase
14%
Postmenopause
14%
Candidate Gene
14%
Interleukin 4
14%
Homeostasis
12%
Gene Frequency
12%
Microsatellite
12%
Tumor Necrosis Factor
12%
Body Mass
12%
HDL-Cholesterol
12%
Glucose Homeostasis
12%
First Trimester Pregnancy
11%
Genetic Variation
11%
HLA-C
10%
Interleukin 6
10%
Multivariate Analysis
10%
Chromosome 6p
9%
Renin Angiotensin Aldosterone System
9%
Insulin Receptor
9%
Comorbidity
9%
Oxidative Stress
9%
Triglyceride
9%
Insulin Sensitivity
8%
Glucose Tolerance Test
8%
Glucose Test
8%
Genomics
8%
Medicine and Dentistry
Abdominal Cancer
19%
Cohort Analysis
18%
Diseases
17%
Liver Cirrhosis
16%
Cancer
15%
Gene Linkage
15%
Quality of Life
14%
Insulin Resistance
14%
Prevalence
14%
Cesarean Section
13%
Comorbidity
13%
Odds Ratio
12%
Psoriasis
11%
Pepsinogen
11%
Single Nucleotide Polymorphism
11%
Diuretics
11%
Gestational Diabetes
10%
Diabetes Mellitus
10%
Infection
10%
Helicobacter Pylori
10%
Cancer Incidence
10%
Microarray Analysis
9%
Prenatal Diagnosis
9%
Mesenchymal Stem Cell
9%
Cancer Mortality
9%
Chromosome 6p
9%
Health Care Cost
9%
Ascites
9%
In Vitro
9%
Receptor Gene
9%
Lochia
9%
Term Birth
9%
Diagnosis
9%
First Trimester Pregnancy
8%
Tumor Necrosis Factor
8%
Haplotype
8%
Large for Gestational Age
8%
Triacylglycerol
8%
Oral Glucose Tolerance Test
7%
Genetic Polymorphism
6%
Cancer Therapy
6%
Functional Assessment
6%
Obesity
6%
Adrenergic Receptor
6%
Platelet
6%
Risk Stratification
6%
Glucose Homeostasis
6%
Neonate
6%
Gestational Age
6%
Dermatomyositis
5%
